Abstract

BackgroundChemotherapy is a principle tool for the control and prevention of piroplasmosis. The search for a new chemotherapy against Babesia and Theileria parasites has become increasingly urgent due to the toxic side effects of and developed resistance to the current drugs. Chalcones have attracted much attention due to their diverse biological activities. With the aim to discover new drugs and drug targets, in vitro and in vivo antibabesial activity of trans-chalcone (TC) and chalcone 4 hydrate (CH) alone and combined with diminazene aceturate (DA), clofazimine (CF) and atovaquone (AQ) were investigated.Methodology/Principal findingsThe fluorescence-based assay was used for evaluating the inhibitory effect of TC and CH on four Babesia species, including B. bovis, B. bigemina, B. divergens, B. caballi, and T. equi, the combination with DA, CF, and AQ on in vitro cultures, and on the multiplication of a B. microti–infected mouse model. The cytotoxicity of compounds was tested on Madin–Darby bovine kidney (MDBK), mouse embryonic fibroblast (NIH/3T3), and human foreskin fibroblast (HFF) cell lines. The half maximal inhibitory concentration (IC50) values of TC and CH against B. bovis, B. bigemina, B. divergens, B. caballi, and T. equi were 69.6 ± 2.3, 33.3 ± 1.2, 64.8 ± 2.5, 18.9 ± 1.7, and 14.3 ± 1.6 μM and 138.4 ± 4.4, 60.9 ± 1.1, 82.3 ± 2.3, 27.9 ± 1.2, and 19.2 ± 1.5 μM, respectively. In toxicity assays, TC and CH affected the viability of MDBK, NIH/3T3, and HFF cell lines the with half maximum effective concentration (EC50) values of 293.9 ± 2.9, 434.4 ± 2.7, and 498 ± 3.1 μM and 252.7 ± 1.7, 406.3 ± 9.7, and 466 ± 5.7 μM, respectively. In the mouse experiment, TC reduced the peak parasitemia of B. microti by 71.8% when administered intraperitoneally at 25 mg/kg. Combination therapies of TC–DA and TC–CF were more potent against B. microti infection in mice than their monotherapies.Conclusions/SignificanceIn conclusion, both TC and CH inhibited the growth of Babesia and Theileria in vitro, and TC inhibited the growth of B. microti in vivo. Therefore, TC and CH could be candidates for the treatment of piroplasmosis after further studies.

Highlights

  • Babesiosis is one of the most severe infections of animals worldwide and has recently gained attention as one of the emerging zoonosis in humans [1, 2]

  • The growth inhibitory assay was conducted on five species: B. bovis, B. bigemina, B. divergens, B. caballi, and T. equi

  • The IC50 values shown by chalcone hydrate (CH) and TC against Babesia and Theileria parasites were comparable to 11.5 and 21.7 μM shown by CH and TC against P. falciparum, respectively, Trypanosoma, and Leishmania [9, 10, 13, 14, 22, 29]

Read more

Summary

Introduction

Babesiosis is one of the most severe infections of animals worldwide and has recently gained attention as one of the emerging zoonosis in humans [1, 2]. Babesia bigemina, and Babesia divergens infect cattle and cause bovine babesiosis. Babesia caballi and Theileria equi (formerly Babesia equi) infect horses, causing equine piroplasmosis. T. equi parasitizes leucocytes and erythrocytes for the completion of its life cycle, causing anemia, weight loss, lethargy, and fever [4], whereas B. caballi directly infects horse erythrocytes in a manner similar to B. bovis and B. bigemina in cattle. Human babesiosis is caused by Babesia microti in North America, while in Europe, it is caused by Babesia divergens. With the aim to discover new drugs and drug targets, in vitro and in vivo antibabesial activity of trans-chalcone (TC) and chalcone 4 hydrate (CH) alone and combined with diminazene aceturate (DA), clofazimine (CF) and atovaquone (AQ) were investigated

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call